AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33166989 — intervention group
Group type: EXPERIMENTAL
Intervention: Study satisfaction
Number of subjects: 49
Study 33166989 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative feedback
Number of subjects: 49
Study 35772045 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 months of oxaliplatin with 6 months of fluoropyrimidine
Number of subjects: 1788
Study 35772045 — intervention group
Group type: COMPARATOR
Intervention: 6 months of oxaliplatin with 6 months of fluoropyrimidine
Number of subjects: 1788
Study 35772045 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 months of oxaliplatin with capecitabine
Number of subjects: 1788
Study 35772045 — intervention group
Group type: COMPARATOR
Intervention: 6 months of oxaliplatin with infusional fluorouracil, leucovorin
Number of subjects: 1788
Study 35772045 — intervention group
Group type: COMPARATOR
Intervention: 6 months of oxaliplatin
Number of subjects: 1788
Study 34648533 — intervention group
Group type: EXPERIMENTAL
Intervention: Meningococcal B vaccine (Bexsero, GlaxoSmithKline)
Number of subjects: 34489
Study 34648533 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustment for social behaviours and personal characteristics
Number of subjects: 34489
Study 34648533 — intervention group
Group type: EXPERIMENTAL
Intervention: Nights out socializing
Number of subjects: 34489
Study 34648533 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 34489
Study 33159735 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle Energy Technique (MET)
Number of subjects: 60
Study 33159735 — intervention group
Group type: COMPARATOR
Intervention: Maitland Mobilizations
Number of subjects: 60
Study 33802464 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 80
Study 33802464 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan
Number of subjects: 80
Study 33802464 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 80
Study 33802464 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 80
Study 32127424 — intervention group
Group type: EXPERIMENTAL
Intervention: Curved rubber bristle interdental cleaner (cRBIC)
Number of subjects: 50
Study 32127424 — intervention group
Group type: COMPARATOR
Intervention: ADA-accepted dental floss (Floss)
Number of subjects: 50
Study 33892613 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress management training
Number of subjects: 206
Study 33892613 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 206
Study 34032691 — intervention group
Group type: EXPERIMENTAL
Intervention: ED-based nursing intervention
Number of subjects: 200
Study 34032691 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 200
Study 32986462 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-questionnaire (aRSD) assessing suicide risk in the 15 preceding days
Number of subjects: 827
Study 32986462 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-questionnaire (aRSD) assessing suicide risk in the context of psychiatric consultation
Number of subjects: 827
Study 34357527 — intervention group
Group type: EXPERIMENTAL
Intervention: Video exercise–based telerehabilitation software (Fizyoweb)
Number of subjects: 50
Study 34357527 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation (paper-based exercise instruction form)
Number of subjects: 50
Study 32804408 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab-lenalidomide-dexamethasone (D-Rd)
Number of subjects: 0
Study 34802113 — intervention group
Group type: EXPERIMENTAL
Intervention: LLETZ-VC
Number of subjects: 218
Study 33650930 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg ondansetron
Number of subjects: 194
Study 33650930 — intervention group
Group type: COMPARATOR
Intervention: 4 mg ondansetron plus 8 mg dexamethasone
Number of subjects: 194
Study 32234902 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab plus platinum-based chemotherapy
Number of subjects: 58
Study 32234902 — intervention group
Group type: COMPARATOR
Intervention: Erlotinib
Number of subjects: 58
Study 34696966 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral ultrasound-guided pectointercostal fascial block (PIFB)
Number of subjects: 39
Study 34696966 — intervention group
Group type: COMPARATOR
Intervention: Transversus thoracic muscle plane block (TTMPB)
Number of subjects: 39
Study 34620406 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe/Simvastatin
Number of subjects: 17999
Study 34620406 — intervention group
Group type: COMPARATOR
Intervention: Placebo/Simvastatin
Number of subjects: 17999
Study 34203181 — intervention group
Group type: EXPERIMENTAL
Intervention: apoE4
Number of subjects: 0
Study 34203181 — intervention group
Group type: EXPERIMENTAL
Intervention: apoE2
Number of subjects: 0
Study 33636369 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-exposure
Number of subjects: 141
Study 33636369 — intervention group
Group type: COMPARATOR
Intervention: Overshadowing
Number of subjects: 141
Study 32256231 — intervention group
Group type: EXPERIMENTAL
Intervention: PST-A method (Polyglot Search Translator)
Number of subjects: 16
Study 32256231 — intervention group
Group type: COMPARATOR
Intervention: Manual method
Number of subjects: 16
Study 35243872 — intervention group
Group type: EXPERIMENTAL
Intervention: hs‐cTnT (high-sensitivity cardiac troponin T)
Number of subjects: 8828
Study 35243872 — intervention group
Group type: EXPERIMENTAL
Intervention: NT‐proBNP (N-terminal pro-B-type natriuretic peptide)
Number of subjects: 8828
Study 35243872 — intervention group
Group type: EXPERIMENTAL
Intervention: hs‐cTnT and NT‐proBNP in the highest tertile
Number of subjects: 8828
Study 35243872 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive-treatment group
Number of subjects: 8828
Study 35243872 — intervention group
Group type: COMPARATOR
Intervention: Standard-treatment group
Number of subjects: 8828
Study 32567357 — intervention group
Group type: EXPERIMENTAL
Intervention: Shortwave diathermy (10 sessions, 5 sessions/week for 2 weeks)
Number of subjects: 76
Study 32567357 — intervention group
Group type: COMPARATOR
Intervention: Placebo shortwave diathermy
Number of subjects: 76
Study 34984835 — intervention group
Group type: EXPERIMENTAL
Intervention: BFR-trial
Number of subjects: 8
Study 34984835 — intervention group
Group type: COMPARATOR
Intervention: CON-trial
Number of subjects: 8
Study 33899216 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic point‐of‐care decision support, combination cardiovascular medications (polypills), pharmacy‐based medication adherence program
Number of subjects: 7165
Study 33899216 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 7165
Study 33899216 — intervention group
Group type: EXPERIMENTAL
Intervention: HealthTracker
Number of subjects: 7165
Study 32678780 — intervention group
Group type: EXPERIMENTAL
Intervention: Staxi® Medical Chair
Number of subjects: 23
Study 32678780 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot wheelchair
Number of subjects: 23
Study 32678780 — intervention group
Group type: COMPARATOR
Intervention: Stryker® Prime TC
Number of subjects: 23
Study 33725854 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixture of 3 probiotics: Lactobacillus acidophilus, Bifidobacterium bifidum, and Lactobacillus rhamnosus (3×10^9 CFU)
Number of subjects: 0
Study 33725854 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixture of 8 probiotics: Lactobacillus acidophilus, Bifidobacterium bifidum, Lactobacillus rhamnosus, Lactobacillus paracasei, Bifidobacterium longum, Bifidobacterium lactis, Lactobacillus defensis, Bifidobacterium animallis (8×10^9 CFU)
Number of subjects: 0
Study 33725854 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33725854 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (3 probiotics, 8 probiotics, placebo)
Number of subjects: 0
Study 32749863 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral acetaminophen
Number of subjects: 138
Study 32749863 — intervention group
Group type: COMPARATOR
Intervention: Intravenous acetaminophen
Number of subjects: 138
Study 35590274 — intervention group
Group type: COMPARATOR
Intervention: 8-week exergaming group
Number of subjects: 200
Study 35590274 — intervention group
Group type: COMPARATOR
Intervention: 8-week companion group
Number of subjects: 200
Study 35590274 — intervention group
Group type: COMPARATOR
Intervention: 5-week companion group
Number of subjects: 200
Study 34135470 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-diagnosis statin use
Number of subjects: 0
Study 34135470 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use after diagnosis
Number of subjects: 0
Study 34135470 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use after diagnosis (started after cancer diagnosis)
Number of subjects: 0
Study 34135470 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use after diagnosis (continuing users)
Number of subjects: 0
Study 34135470 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use after diagnosis (for endometrioid cancers)
Number of subjects: 0
Study 32027744 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 25
Study 35889755 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin treatment in DM + I/R rats
Number of subjects: 4
Study 35889755 — intervention group
Group type: COMPARATOR
Intervention: Citrate buffer (control group)
Number of subjects: 4
Study 35889755 — intervention group
Group type: COMPARATOR
Intervention: DM (streptozotocin, 65 mg/k, single dose, i.v.)
Number of subjects: 4
Study 35889755 — intervention group
Group type: COMPARATOR
Intervention: DM + I/R (DM rats with renal pedicle clamped for 30 min)
Number of subjects: 4
Study 34890584 — intervention group
Group type: EXPERIMENTAL
Intervention: snNICUs
Number of subjects: 22081
Study 34890584 — intervention group
Group type: COMPARATOR
Intervention: non-snNICUs
Number of subjects: 22081
Study 32795619 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanochemical ablation (MOCA)
Number of subjects: 117
Study 32795619 — intervention group
Group type: COMPARATOR
Intervention: Endovenous laser ablation (EVLA)
Number of subjects: 117
Study 32795619 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 117
Study 35068018 — intervention group
Group type: EXPERIMENTAL
Intervention: 16F Foley catheter
Number of subjects: 127
Study 35068018 — intervention group
Group type: EXPERIMENTAL
Intervention: 22F Foley catheter
Number of subjects: 127
Study 35068018 — intervention group
Group type: EXPERIMENTAL
Intervention: 28F Foley catheter
Number of subjects: 127
Study 32537348 — intervention group
Group type: EXPERIMENTAL
Intervention: ALGINATE
Number of subjects: 95
Study 32537348 — intervention group
Group type: COMPARATOR
Intervention: NPWT
Number of subjects: 95
Study 32537348 — intervention group
Group type: COMPARATOR
Intervention: ALGINATE vs NPWT
Number of subjects: 95
Study 36484188 — intervention group
Group type: EXPERIMENTAL
Intervention: Pricking‐cupping therapy
Number of subjects: 70
Study 36484188 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture‐cupping therapy
Number of subjects: 70
Study 32624400 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-incisional TAP block (n=40)
Number of subjects: 80
Study 32624400 — intervention group
Group type: COMPARATOR
Intervention: Post-incisional TAP block (n=40)
Number of subjects: 80
Study 32624400 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study 32933955 — intervention group
Group type: EXPERIMENTAL
Intervention: RTS,S/AS01E vaccine and four courses of SMC SP+AQ
Number of subjects: 5920
Study 32933955 — intervention group
Group type: COMPARATOR
Intervention: SMC SP+AQ placebo
Number of subjects: 5920
Study 32933955 — intervention group
Group type: COMPARATOR
Intervention: Rabies vaccine in year 1 and hepatitis A vaccine in years 2 and 3 with four cycles of SMC SP+AQ
Number of subjects: 5920
Study 34476770 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive Brivaracetam (BRV)
Number of subjects: 1029
Study 34476770 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive Brivaracetam (BRV) in LEV-naive patients
Number of subjects: 1029
Study 34476770 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive Brivaracetam (BRV) in patients with prior LEV use and discontinuation due to insufficient efficacy
Number of subjects: 1029
Study 34476770 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive Brivaracetam (BRV) in patients with prior LEV use and discontinuation due to AEs
Number of subjects: 1029
Study 34476770 — intervention group
Group type: COMPARATOR
Intervention: Adjunctive Brivaracetam (BRV) with strong enzyme-inducing antiseizure medications (EiASMs)
Number of subjects: 1029
Study 34476770 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive Brivaracetam (BRV) with sodium channel blockers (SCBs)
Number of subjects: 1029
Study 36116089 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography guidance
Number of subjects: 621
Study 36116089 — intervention group
Group type: COMPARATOR
Intervention: No ultrasonography guidance
Number of subjects: 621
Study 34945780 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade (NMB)
Number of subjects: 0
Study 34945780 — intervention group
Group type: COMPARATOR
Intervention: Moderate neuromuscular blockade (NMB)
Number of subjects: 0
Study 32389507 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondhand smoking most of their work time
Number of subjects: 49569
Study 32389507 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondhand smoking most of their adult living time
Number of subjects: 49569
Study 32389507 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondhand smoking most of the adult time
Number of subjects: 49569
Study 35941737 — intervention group
Group type: EXPERIMENTAL
Intervention: DMPA-IM
Number of subjects: 58
Study 35941737 — intervention group
Group type: COMPARATOR
Intervention: Cu-IUD
Number of subjects: 58
Study 35941737 — intervention group
Group type: COMPARATOR
Intervention: LNG implant
Number of subjects: 58
Study 33597044 — intervention group
Group type: EXPERIMENTAL
Intervention: School teacher training programme to teach the '.b' programme as part of compulsory classroom teaching.
Number of subjects: 2000
Study 32703227 — intervention group
Group type: EXPERIMENTAL
Intervention: Carapa procera
Number of subjects: 336
Study 32703227 — intervention group
Group type: EXPERIMENTAL
Intervention: Lophira lanceolata
Number of subjects: 336
Study 32703227 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentadesma butyracea
Number of subjects: 336
Study 32703227 — intervention group
Group type: EXPERIMENTAL
Intervention: General population preferences
Number of subjects: 336
Study 32703227 — intervention group
Group type: EXPERIMENTAL
Intervention: Tree selection for oil-seed collection
Number of subjects: 336
Study 32703227 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservation actions
Number of subjects: 336
Study 35506932 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumatic partial weight support treadmill
Number of subjects: 109
Study 34677083 — intervention group
Group type: EXPERIMENTAL
Intervention: 2D HD
Number of subjects: 45
Study 34677083 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D HD
Number of subjects: 45
Study 34677083 — intervention group
Group type: EXPERIMENTAL
Intervention: 4K HD
Number of subjects: 45
Study 33170481 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated symptom management and lifestyle intervention (SMLI)
Number of subjects: 45
Study 33170481 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 45
Study 32958408 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT): 4 sets of 4 minutes at 80%–90% V̇O2 reserve, alternating with 3 minutes at 50%–60% V̇O2 reserve
Number of subjects: 21
Study 32958408 — intervention group
Group type: COMPARATOR
Intervention: Moderate-intensity continuous training (MICT): 28 minutes continuously at 50%–60% V̇O2 reserve
Number of subjects: 21
Study 35941831 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthokeratology lenses (OKL)
Number of subjects: 49
Study 35941831 — intervention group
Group type: COMPARATOR
Intervention: Single-vision spectacles (SVS)
Number of subjects: 49
Study 33188886 — intervention group
Group type: EXPERIMENTAL
Intervention: pecavaptan 30 mg/d
Number of subjects: 571
Study 33188886 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 571
Study 33188886 — intervention group
Group type: EXPERIMENTAL
Intervention: pecavaptan or diuretics as monotherapy
Number of subjects: 571
Study 36472360 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Restructuring (CR) intervention
Number of subjects: 137
Study 36472360 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 137
Study 33446347 — intervention group
Group type: EXPERIMENTAL
Intervention: Well-being intervention derived from Well-Being Therapy (WBT)
Number of subjects: 0
Study 32757999 — intervention group
Group type: EXPERIMENTAL
Intervention: Pericapsular injection of 30 mL of ropivacaine and 12 mg of morphine
Number of subjects: 64
Study 32757999 — intervention group
Group type: COMPARATOR
Intervention: Lumbar plexus blockade
Number of subjects: 64
Study 34843023 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination group (0.3% and 0.15% HA)
Number of subjects: 76
Study 34843023 — intervention group
Group type: COMPARATOR
Intervention: 0.3% HA group
Number of subjects: 76
Study 34843023 — intervention group
Group type: COMPARATOR
Intervention: 0.15% HA group
Number of subjects: 76
Study 33025865 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 34068170 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocoa flavanol (450‐500 mg)
Number of subjects: 12
Study 34068170 — intervention group
Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 12
Study 34035391 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional CYP2D6
Number of subjects: 81
Study 34035391 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-functional CYP2D6 (poor metabolizers)
Number of subjects: 81
Study 34035391 — intervention group
Group type: COMPARATOR
Intervention: Other CYPs
Number of subjects: 81
Study 36471349 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised biopsychosocial rehabilitation programme of 14 weeks
Number of subjects: 112
Study 36471349 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 112
Study 33306118 — intervention group
Group type: EXPERIMENTAL
Intervention: Unauthorized immigrants
Number of subjects: 47199
Study 33306118 — intervention group
Group type: EXPERIMENTAL
Intervention: Authorized immigrants
Number of subjects: 47199
Study 33306118 — intervention group
Group type: EXPERIMENTAL
Intervention: US-born individuals
Number of subjects: 47199
Study 33570985 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based intervention focused on increasing adolescents' ethnic-racial identity (ERI) exploration
Number of subjects: 218
Study 33570985 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 218
Study 32494981 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 plus cisplatin (SP)
Number of subjects: 50
Study 32494981 — intervention group
Group type: COMPARATOR
Intervention: capecitabine plus cisplatin (XP)
Number of subjects: 50
Study 35876124 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose treatment
Number of subjects: 6522
Study 35876124 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular events (MI, stroke, heart failure, angina)
Number of subjects: 6522
Study 33064299 — intervention group
Group type: EXPERIMENTAL
Intervention: Inosine 5'-monophosphate (IMP)
Number of subjects: 55
Study 33064299 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 32231103 — intervention group
Group type: EXPERIMENTAL
Intervention: PLANT (Animal 30%/plant 70%)
Number of subjects: 136
Study 32231103 — intervention group
Group type: EXPERIMENTAL
Intervention: 50/50 (Animal 50%/plant 50%)
Number of subjects: 136
Study 32231103 — intervention group
Group type: COMPARATOR
Intervention: ANIMAL (Animal 70%/plant 30%)
Number of subjects: 136
Study 35199973 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine in adductor canal block (bupACB)
Number of subjects: 385
Study 35199973 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine in femoral nerve block (bupFNB)
Number of subjects: 385
Study 35199973 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone in adductor canal block (dexACB)
Number of subjects: 385
Study 35199973 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone in femoral nerve block (dexFNB)
Number of subjects: 385
Study 35199973 — intervention group
Group type: COMPARATOR
Intervention: Overall pain control
Number of subjects: 385
Study 35199973 — intervention group
Group type: COMPARATOR
Intervention: Rescue analgesia needed
Number of subjects: 385
Study 35199973 — intervention group
Group type: COMPARATOR
Intervention: Percentage of timepoints without pain
Number of subjects: 385
Study 35199973 — intervention group
Group type: COMPARATOR
Intervention: Mean VRS<inf>11</inf> score
Number of subjects: 385
Study 35199973 — intervention group
Group type: COMPARATOR
Intervention: Use of intravenous morphine
Number of subjects: 385
Study 34106458 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride varnish applications every 6 months
Number of subjects: 0
Study 34106458 — intervention group
Group type: COMPARATOR
Intervention: No fluoride varnish applications
Number of subjects: 0
Study 32651634 — intervention group
Group type: EXPERIMENTAL
Intervention: INTERMITTENT (4 meals per day separated by 5 hours)
Number of subjects: 20
Study 32651634 — intervention group
Group type: COMPARATOR
Intervention: CONTINUOUS (24 hours day-1 at a constant rate)
Number of subjects: 20
Study 32651634 — intervention group
Group type: COMPARATOR
Intervention: CONTINUOUS
Number of subjects: 20
Study 32651634 — intervention group
Group type: EXPERIMENTAL
Intervention: INTERMITTENT
Number of subjects: 20
Study 34111772 — intervention group
Group type: EXPERIMENTAL
Intervention: Al-Anon Intensive Referral (AIR)
Number of subjects: 31
Study 33435475 — intervention group
Group type: EXPERIMENTAL
Intervention: Gum Arabic (GA) 20 g daily for 12 weeks
Number of subjects: 80
Study 33435475 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1 g pectin)
Number of subjects: 80
Study 34255069 — intervention group
Group type: EXPERIMENTAL
Intervention: Trp-3 (3 g)
Number of subjects: 25
Study 34255069 — intervention group
Group type: EXPERIMENTAL
Intervention: Trp-1.5 (1.5 g)
Number of subjects: 25
Study 34255069 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 25